The Bioidentical Debate
The main problem with BHRT, she says, is how women receive their medicines. "[BHRT] is a billion-dollar industry—probably a trillion-dollar industry after last week's show—which is really marketing to women to say: 'This is safe, and the other stuff isn't. This is going to protect against breast cancer.' How can they say this without data? My concern is [with] many of the so-called experts that are prescribing it. I've talked to some of the women here. They've done it online, they have doctors who don't examine them, they're not gynecologists," Dr. Streicher says. "Women deserve transparency in the pharmaceutical industry."
Suzanne says her use of HRT is about choice. "It's restoration versus deterioration," she says. "By replacing what I have lost in the aging process, by putting back in the exact ratio that my body requires, individualized just for me, I am experiencing the best years of my life. I thought at 62, I'd be going downhill. I feel better at 62 than I have ever felt ever in my whole life."